在瘤干细胞类细胞中,缺氧诱导的单碳代谢重编程
Xuan-Cheng He1,2,3, Jian Wang1,4, Min-Yang Shi1,4
1State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Life medicine
|January 28, 2025
概括
缺氧通过影响DHFR和MAT2A.改变质母细胞 (GSCs) 中的一碳代谢. 向MAT2A或限制甲因抑制了GSC的瘤性,为质母细胞瘤 (GBM) 提供了新的治疗策略.
科学领域:
- * 神经瘤学 * 神经瘤学
- * 癌症代谢 * 癌症代谢
- * 质母细胞干细胞 (GSCs)
背景情况:
- * 质母细胞瘤 (GBM) 中的缺氧位对质母细胞 (GSC) 存活至关重要,推动瘤的开始,进展和复发.
- * 低氧状态下的GSCs中变化的代谢途径与GBM有关,但单碳代谢变化的具体机制尚不清楚.
研究的目的:
- * 阐明缺氧改变GSCs中单碳代谢的机制.
- * 调查DHFR和MAT2A在低氧诱导的GSC增殖和瘤性中的作用.
- * 评估向GBM中的氨酸循环或MAT2A的治疗潜力.
主要方法:
- *GBM瘤球细胞是在低氧条件下培养的.
- *分析了DHFR和MAT2A的表达水平.
- *进行了细胞增殖试验.
- * 抑制 metionin 循环和 MAT2A 对其对瘤启动能力的影响进行了评估.
主要成果:
- *低氧诱导DHFR的下调和MAT2A在GBM瘤球细胞的上调.
- * 这些变化赋予了GSC的叶酸独立的扩散能力.
- * 短期抑制甲因循环或MAT2A显著损害了GBM细胞的瘤发起能力.
结论:
- * 低氧通过调节DHFR和MAT2A表达,显著改变GBM GSC中的单碳代谢.
- * 向MAT2A或限制 metionin摄入量代表了一种有前途的治疗策略,以抑制GBM瘤性.
- * 这项研究为低氧环境中GSCs的代谢适应提供了新的见解.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
01:32Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K